AdaptHealth Corp. (NASDAQ: AHCO) has appointed Harriss T. Currie as its new Chief Financial Officer, effective Wednesday. Currie will succeed Jason Clemens, who will continue to assist with the transition until October 1, 2026.
Currie brings extensive experience in the healthcare and medical technology sectors. He has served as Chief Financial Officer at Luminex Corp. (NASDAQ: LMNX) for over 15 years, leading the company through its sale to DiaSorin in 2021. Prior to that, he held CFO roles at Health Track Rx (2025-2026) and Impulse Dynamics (2022-2023). Currie also served as President of the Regenerative Medicine division at 3D Systems (NYSE: DDD) from 2023 to 2025. His professional background also includes a tenure as an audit manager at Deloitte & Touche. Currie holds an MBA from the McCombs School of Business at the University of Texas at Austin.
AdaptHealth provides healthcare-at-home solutions, including home medical equipment, medical supplies, and related services. The company operates through four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. It serves approximately 4.5 million patients annually across all 50 states through a network of approximately 670 locations in 48 states.
Suzanne Foster, Chief Executive Officer of AdaptHealth, expressed enthusiasm for Currie's appointment, stating, "We are delighted to welcome Harriss to AdaptHealth and look forward to the meaningful contributions we expect he will make in both the short and long term."
